Gene patents are discoveries, not inventions and patenting discoveries may hamper future innovations in developing cost-effective patient care products and services. Banning gene patents may offer incredible opportunities for innovations that can attract investments to create sustainable entrepreneurial establishments and scientific jobs, which may be significantly higher that gene patents alone can offer. In contrast, granting gene patents may lead to innovation bottlenecks that favor fewer inventions, restricted entrepreneurial initiatives, limited job growth, and monopoly. Read the full blog: http://www.sciclips.com/sciclips/blogArticle....